Financials
Financial year 2025
Dr. Klaas Prenen from Tienen, company number BE0757691546, closed financial year 2025 with a result of € 31,261 after tax. For that financial year Dr. Klaas Prenen recorded a gross margin of € 48,454 and equity of € 191,502. Compared with financial year 2024, the result moved from € 52,618 to € 31,261. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 11, 2026.
€ 191,502
▲ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 31,261
▼ 41% vs 2024
Profit after tax over the fiscal year.
€ 189,347
▲ 18% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 188,502.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 653
▲ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,292
▼ 88% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 43,110 | € 61,854 | € 83,558 | € 48,454 | ▼ 42% |
| Profit after taxes | € 24,357 | € 42,500 | € 52,618 | € 31,261 | ▼ 41% |
| Equity | € 65,123 | € 107,623 | € 160,241 | € 191,502 | ▲ 20% |
| Total debts | € 32,705 | € 18,031 | € 13,721 | € 5,972 | ▼ 56% |
| Cash | € 88,318 | € 115,143 | € 159,813 | € 189,347 | ▲ 18% |
| Land & buildings | € 1,594 | € 1,309 | € 1,023 | € 738 | ▼ 28% |
| Retained profit | € 62,123 | € 104,623 | € 157,241 | € 188,502 | ▲ 20% |
| Balance sheet total | € 97,828 | € 125,654 | € 173,962 | € 197,474 | ▲ 14% |
Key figures of Dr. Klaas Prenen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Dr. Klaas Prenen the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr. Klaas Prenen?
What happened at Dr. Klaas Prenen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 31,261 (▼ 41% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Etterbeek. KBO
- New establishment in Vilvoorde. KBO
In short
From € 24,357 profit in 2022 to € 31,261 profit in 2025.
Paid € 75,441 in corporate taxes since 2022.
Best year ever: 2024, with € 52,618 profit.
Management
Behind Dr. Klaas Prenen is Klaas Prenen.
Directors
According to the 2025 annual accounts
Klaas Prenen
Director
Establishments
Establishment units
Physical locations of this company
Oude Weg 16
3300 Tienen
Linthoutstraat 150
1040 Etterbeek
Active since 30 October 2020
Gendarmeriestraat 65
1800 Vilvoorde
Active since 30 October 2020
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- PRENEN Klaas Willem(oprichter) 100%
Details
- Company number
- 0757.691.546
- VAT number
- BE 0757.691.546
- Registered office
- Oude Weg 16, 3300 Tienen
- Names & denominations
- Dr. Klaas Prenen
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 October 2020
- Peppol
- Active · Active since 19 Dec 2024